Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(48)
•••
Comment by ChiefBroncoon Jul 26, 2019 1:27pm
70 Views
Post# 29964745

RE:RE:RE:RE:RE:RE:RE:RE:arcview and institutional funds

RE:RE:RE:RE:RE:RE:RE:RE:arcview and institutional funds
TANT3HILD3 wrote:
ChiefBronco wrote: I contacted them in the beginning of the week and they confirmed they had product ready to go so I guess your wrong again. They will be open to medical users very very soon thats what the gentleman told me, and no its not fake news its very honest truth so if you dont believe me go ahead and call them for yourself....


So you're saying they have violated their quiet period they say they are in? I'm sure the regulators would like to hear more about it. Please go on. Either that or quiet period is just horse sheet, but no surprise there either.






Quiet period only apply to executive from the company not share holders and employees. I called as a client to buy product and the employee told me that they had product in the vault and they would be ready very very soon.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities